This activity already occurred and is no longer available.
JAAPA CME Post-Test August 2016
Benign prostatic hyperplasia: A clinical review. Direct oral anticoagulants for venous thromboembolism treatment and prophylaxis. Member: Free | Nonmember: $25

Benign Prostatic Hyperplasia: A Clinical Review

Danielle Skinder, PA-C; Ilana Zacharia, PA-C; Jillian Studin, PA-C; Jean Covino, DHSc, MPA, PA-C

Benign prostatic hyperplasia (BPH) is an increasingly common diagnosis seen in men over age 50 years. Primary care providers must be aware of patient presentation, diagnostic tests, appropriate lifestyle modifications, treatment options, and potential complications in order to properly manage and educate patients with BPH. If left untreated, BPH can significantly decrease a man’s quality of life; however, many pharmacologic and surgical treatments are available to control the symptoms.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Discuss the cause, pathophysiology, and risk factors for developing BPH.
  • Explain the clinical presentation of BPH and the screening methods and diagnostic tests used in its evaluation.
  • Discuss management options for patients with BPH.

Direct Oral Anticoagulants for Venous Thromboembolism Treatment and Prophylaxis

Brian K. Yorkgitis, PA-C, DO

Direct oral anticoagulants are a popular option for prevention and treatment of venous thromboembolism. However, they possess significantly different pharmacologic properties from warfarin. This activity reviews approved direct oral anticoagulants, their indications, pharmacologic properties, monitoring, and reversal strategies.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • List the available direct oral anticoagulants in the factor Xa inhibitor and direct thrombin inhibitor classes.
  • Discuss the indications, pharmacologic properties, monitoring, and reversal strategies for direct oral anticoagulants.

Accreditation Statement

This activity has been reviewed and is approved for a maximum of 1.0 AAPA Category 1 CME credit by the PA Review Panel. Participants should only claim credit commensurate with their participation in the CME activity. This program was planned in accordance with AAPA’s CME Standards. 

Disclosure Policy Statement

It is the policy of AAPA to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member has with the commercial interest of any commercial product discussed in an educational presentation. The participating faculty reported the following:

At New York-Presbyterian/Columbia University Medical Center in New York City, Danielle Skinder practices interventional cardiology, Ilana Zacharia practices oncology, and Jillian Studin practices in the cardiothoracic ICU. Jean Covino is a clinical professor and director of didactic education at Pace University-Lenox Hill Hospital and practices at Medemerge Family Practice in Green Brook, N.J. Brian K. Yorkgitis practices in the Division of Acute Care Surgery at the University of Florida-Jacksonville. The authors has disclosed no potential conflicts of interest, financial or otherwise.

AAPA offers no returns or refunds for online CME activities purchased through the AAPA store. All sales are final.

Type:     Journal-based CME
7509 Registered Users